Samyang Biopharm Corporation (KRX:0120G0)
South Korea · Delayed Price · Currency is KRW 48,500
-700 (-1.42%)
At close: Oct 2, 2026
Samyang Biopharm Market Cap
Samyang Biopharm has a market cap or net worth of 365.84 billion as of October 1, 2026.
Market Cap
365.84B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
48,500.00
ChartMarket Cap Chart
Since November 24, 2025, Samyang Biopharm's market cap has increased from 224.56B to 365.84B, an increase of 62.91%. That is a compound annual growth rate of 77.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 365.84B | -6.29% |
| Dec 30, 2025 | 390.38B | 73.84% |
| Nov 24, 2025 | 224.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BioNote | 470.25B |
| i-SENS | 458.09B |
| T&L Co., Ltd. | 447.99B |
| WON TECH | 424.39B |
| Sky Labs | 404.32B |
| Curexo | 335.44B |
| ToolGen | 322.93B |
| Value Added Technology | 262.33B |